Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Orexin receptor type 2 (Homo sapiens (Human)) | BDBM203462 (US9242995, 1-21) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.700 | -54.4 | n/a | n/a | n/a | n/a | n/a | n/a | 37 |
MERCK SHARP & DOHME CORP. US Patent | Assay Description In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with ... | US Patent US9242995 (2016) BindingDB Entry DOI: 10.7270/Q2736PQS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin receptor type 2 (Homo sapiens (Human)) | BDBM203460 (US9242995, 1-8) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 3.80 | -50.0 | n/a | n/a | n/a | n/a | n/a | n/a | 37 |
MERCK SHARP & DOHME CORP. US Patent | Assay Description In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with ... | US Patent US9242995 (2016) BindingDB Entry DOI: 10.7270/Q2736PQS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Orexin receptor type 2 (Homo sapiens (Human)) | BDBM203461 (US9242995, 1-12) | PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 10.8 | -47.3 | n/a | n/a | n/a | n/a | n/a | n/a | 37 |
MERCK SHARP & DOHME CORP. US Patent | Assay Description In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with ... | US Patent US9242995 (2016) BindingDB Entry DOI: 10.7270/Q2736PQS | |||||||||||
More data for this Ligand-Target Pair |